Rubix LS Blog

Our experience from +12 million patients (and counting) is at your disposal for free!

Stem Cell Clinical Trials in 2024: Risks, Trends, and Success Chances

Regenerating damaged organs, curing chronic diseases, and self-healing abilities are no longer sci-fi. Stem cell therapy is the closest...

Rubix LS Partners With BioMark To Advance Blood-Based Cancer Screenings

Vancouver, British Columbia – (February 28, 2024) - BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS:...

Putting Patients First: Rubix Life Sciences' Guide to Patient-Centric Regulatory Compliance

Regulatory compliance is a crucial aspect of clinical research. And more so in multicultural trials. In this article, we will address...